Results 171 to 180 of about 12,272 (191)

PCSK9 Inhibitors and Cardiovascular Events

New England Journal of Medicine, 2015
Marc S, Sabatine, Scott M, Wasserman, Evan A, Stein   +2 more
openaire   +5 more sources

Application of PCSK9 Inhibitors in Practice

Circulation Research, 2019
Jonathan Q Purnell, Jessica Minnier, Sérgio Fazio   +2 more
exaly  

The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective

International Journal of Cardiology, 2018
, Danny Yearn Hian Liew, Ella Zomer
exaly  

The effect of PCSK9 inhibitors on brain stroke prevention: A systematic review and meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases, 2021
exaly  

The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors

Current Pharmaceutical Design, 2019
Eleni Theocharidou, Alexandros Sachinidis, Olga Giouleme   +2 more
exaly  

A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases

Current Topics in Medicinal Chemistry, 2019
Bo Chen, Xin Shi
exaly  

Heterocyclic inhibitors of PCSK9

2018
TREUTLEIN HERBERT, ZENG JUN, DIXON IAN, JAMES IAN, PALMER JAMES T   +4 more
openaire   +3 more sources

Pleiotropic Anti-atherosclerotic Effects of PCSK9 Inhibitors From Molecular Biology to Clinical Translation

Current Atherosclerosis Reports, 2018
, Peter Tóth
exaly  

<p>Safety and Tolerability of PCSK9 Inhibitors: Current Insights</p>

Clinical Pharmacology: Advances and Applications, 2020
exaly  

CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism

Atherosclerosis, 2014
Amar Bahadur Singh Or Amar B Singh
exaly